Purpose To examine disease progression in age-related macular degeneration (AMD) at 2
distinct stages, progression to geographic atrophy (GA) versus GA expansion, by …

PURPOSE: We sought to determine whether genotype is associated with rate of growth of
geographic atrophy (GA) in eyes with age-related macular degeneration (AMD). DESIGN …

Purpose To analyze the prevalence, incidence, and clinical characteristics of eyes with
geographic atrophy (GA) in age-related macular degeneration (AMD), including clinical and …

Purpose To explore whether phenotypes in geographic atrophy (GA) secondary to age-
related macular degeneration can be separated into 2 or more partially distinct subtypes and …

Importance Identification of the genetic risk factors that contribute to geographic atrophy (GA)
could lead to advancements in interventional trials and/or therapeutic approaches for …

Pharmacologic treatment of atrophic age-related macular dege... : Current Opinion in
Ophthalmology Pharmacologic treatment of atrophic age-related macular degeneration …

Importance Age-related macular degeneration (AMD) is a common threat to vision loss in
individuals older than 50 years. While neovascular complications in AMD are treatable …

Geographic atrophy (GA) of the retinal pigment epithelium (RPE) is a devastating
complication of age-related macular degeneration (AMD). GA may be classified as drusen …

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD)
that leads to progressive and irreversible loss of visual function. Geographic atrophy is …

Treatment for atrophic macular degeneration : Current Opinion in Ophthalmology Treatment for
atrophic macular degeneration : Current Opinion in Ophthalmology Log in or Register Subscribe …